ChitogenX Inc.

CNSX:CHGX Stock Report

Market Cap: CA$1.2m

ChitogenX Management

Management criteria checks 2/4

ChitogenX's CEO is Pierre Laurin, appointed in Feb 2024, has a tenure of less than a year. directly owns 3.13% of the company’s shares, worth CA$39.08K. The average tenure of the management team and the board of directors is 6.3 years and 5.6 years respectively.

Key information

Pierre Laurin

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership3.1%
Management average tenure6.3yrs
Board average tenure5.6yrs

Recent management updates

Recent updates

CEO

Pierre Laurin (63 yo)

less than a year

Tenure

Mr. Pierre Laurin, B.Sc.Pharm. M.Sc. serves as Chairman of ChitogenX Inc. since July 21, 2022 and serves as its Interim CEO since February 28, 2024. He serves as Director at ChitogenX Inc. (formerly known...

Leadership Team

NamePositionTenureCompensationOwnership
Pierre Laurin
Interim CEO & Chairmanless than a yearno data3.13%
CA$ 39.1k
Luc Mainville
Senior VP & CFO6.3yrsCA$187.18k5.19%
CA$ 64.7k
Guy-Paul Allard
VP of Legal Affairs & Corporate Secretary8.6yrsno data1.48%
CA$ 18.5k
Jonathan Sackier
Senior Vice President of Medical Affairs2.7yrsCA$280.27k0.76%
CA$ 9.4k
Frédéric Dumais
Director of Communications & Investor Relationsno datano datano data
Benedek Simo
Controller6.3yrsno datano data

6.3yrs

Average Tenure

Experienced Management: CHGX's management team is seasoned and experienced (6.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Pierre Laurin
Interim CEO & Chairman5.6yrsno data3.13%
CA$ 39.1k
Jack Farr
Member of Clinical Advisory Boardno datano datano data
Steven Saviuk
Director9.9yrsno data0.10%
CA$ 1.3k
Timothy Cunningham
Independent Director3.6yrsno datano data
Scott Rodeo
Member of Clinical Advisory Boardno datano datano data
Patrick O'Donnell
Independent Director3.9yrsno datano data
Brent Norton
Director8.5yrsno data1.83%
CA$ 22.8k
Martyn Snow
Member of Clinical Advisory Boardno datano datano data
Caroline Hoemann
Member of Scientific Advisory Boardno datano data4.35%
CA$ 54.2k
Jacques Toueg
Member of Clinical Advisory Board6.8yrsno datano data
Howard Walthall
Independent Director3.6yrsno datano data

5.6yrs

Average Tenure

63yo

Average Age

Experienced Board: CHGX's board of directors are considered experienced (5.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 11:08
End of Day Share Price 2025/01/17 00:00
Earnings2024/10/31
Annual Earnings2024/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ChitogenX Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gregory AurandNOBLE Capital Markets, Inc.